CA2720264C - A membrane for supporting the growth of retinal pigmented epithelial cells - Google Patents
A membrane for supporting the growth of retinal pigmented epithelial cells Download PDFInfo
- Publication number
- CA2720264C CA2720264C CA2720264A CA2720264A CA2720264C CA 2720264 C CA2720264 C CA 2720264C CA 2720264 A CA2720264 A CA 2720264A CA 2720264 A CA2720264 A CA 2720264A CA 2720264 C CA2720264 C CA 2720264C
- Authority
- CA
- Canada
- Prior art keywords
- membrane
- cells
- membrane according
- pores
- pigmented epithelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 123
- 230000002207 retinal effect Effects 0.000 title claims abstract description 17
- 230000012010 growth Effects 0.000 title claims abstract description 11
- 210000001127 pigmented epithelial cell Anatomy 0.000 title claims description 12
- 239000011148 porous material Substances 0.000 claims abstract description 31
- 238000000576 coating method Methods 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims abstract description 22
- 239000011248 coating agent Substances 0.000 claims abstract description 19
- 238000010899 nucleation Methods 0.000 claims abstract description 18
- 206010064930 age-related macular degeneration Diseases 0.000 claims abstract description 13
- 208000002780 macular degeneration Diseases 0.000 claims abstract description 12
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 239000002243 precursor Substances 0.000 claims abstract description 9
- 108090000288 Glycoproteins Proteins 0.000 claims abstract description 5
- 102000003886 Glycoproteins Human genes 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 146
- 229920000728 polyester Polymers 0.000 claims description 15
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 14
- -1 poly(tetrafluoroethene) Polymers 0.000 claims description 14
- 108010085895 Laminin Proteins 0.000 claims description 10
- 229920002635 polyurethane Polymers 0.000 claims description 10
- 239000004814 polyurethane Substances 0.000 claims description 10
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 7
- 108010082117 matrigel Proteins 0.000 claims description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 4
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- 239000003124 biologic agent Substances 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 239000002831 pharmacologic agent Substances 0.000 claims description 3
- 230000000144 pharmacologic effect Effects 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 229920006324 polyoxymethylene Polymers 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 230000000593 degrading effect Effects 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 108010067306 Fibronectins Proteins 0.000 claims 2
- 102000016359 Fibronectins Human genes 0.000 claims 2
- 229920000162 poly(ureaurethane) Polymers 0.000 claims 1
- 210000004379 membrane Anatomy 0.000 description 81
- 229920000642 polymer Polymers 0.000 description 22
- 239000000243 solution Substances 0.000 description 14
- 230000010261 cell growth Effects 0.000 description 13
- 239000010410 layer Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 9
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 7
- 108010057670 laminin 1 Proteins 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 6
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 6
- 238000010494 dissociation reaction Methods 0.000 description 6
- 230000005593 dissociations Effects 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 108091008695 photoreceptors Proteins 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 229920001222 biopolymer Polymers 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 201000004569 Blindness Diseases 0.000 description 4
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000002054 transplantation Methods 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 230000004393 visual impairment Effects 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 229930182816 L-glutamine Natural products 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 208000000208 Wet Macular Degeneration Diseases 0.000 description 3
- 238000003570 cell viability assay Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 238000004624 confocal microscopy Methods 0.000 description 3
- 238000005138 cryopreservation Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000000386 microscopy Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 108010058237 plasma protein fraction Proteins 0.000 description 3
- 229940002993 plasmanate Drugs 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000001525 retina Anatomy 0.000 description 3
- 239000004017 serum-free culture medium Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 208000008069 Geographic Atrophy Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004830 Super Glue Substances 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000001775 bruch membrane Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 229930182912 cyclosporin Natural products 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 229920006267 polyester film Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000001665 trituration Methods 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 230000004382 visual function Effects 0.000 description 2
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 101000945963 Homo sapiens CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
- 101000942967 Homo sapiens Leukemia inhibitory factor Proteins 0.000 description 1
- 101000729271 Homo sapiens Retinoid isomerohydrolase Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100119135 Mus musculus Esrrb gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920005439 Perspex® Polymers 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000002367 Retinal Perforations Diseases 0.000 description 1
- 102100031176 Retinoid isomerohydrolase Human genes 0.000 description 1
- 102100040756 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 208000027073 Stargardt disease Diseases 0.000 description 1
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000003349 alamar blue assay Methods 0.000 description 1
- 210000000411 amacrine cell Anatomy 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000002287 horizontal cell Anatomy 0.000 description 1
- 102000046645 human LIF Human genes 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000508 neurotrophic effect Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000000608 photoreceptor cell Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 150000003726 retinal derivatives Chemical class 0.000 description 1
- 210000003994 retinal ganglion cell Anatomy 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0806746.4 | 2008-04-14 | ||
| GBGB0806746.4A GB0806746D0 (en) | 2008-04-14 | 2008-04-14 | Membrane |
| PCT/GB2009/000917 WO2009127809A1 (en) | 2008-04-14 | 2009-04-08 | Membrane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2720264A1 CA2720264A1 (en) | 2009-10-22 |
| CA2720264C true CA2720264C (en) | 2016-09-27 |
Family
ID=39433610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2720264A Active CA2720264C (en) | 2008-04-14 | 2009-04-08 | A membrane for supporting the growth of retinal pigmented epithelial cells |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8642072B2 (enExample) |
| EP (1) | EP2265711B1 (enExample) |
| JP (1) | JP5552478B2 (enExample) |
| KR (2) | KR101317094B1 (enExample) |
| CN (1) | CN102016009B (enExample) |
| AU (1) | AU2009237462B2 (enExample) |
| BR (1) | BRPI0910936A2 (enExample) |
| CA (1) | CA2720264C (enExample) |
| CO (1) | CO6311115A2 (enExample) |
| DK (1) | DK2265711T3 (enExample) |
| ES (1) | ES2665284T3 (enExample) |
| GB (1) | GB0806746D0 (enExample) |
| IL (1) | IL208745A (enExample) |
| MX (1) | MX2010011232A (enExample) |
| MY (1) | MY159049A (enExample) |
| NZ (1) | NZ587753A (enExample) |
| RU (1) | RU2530169C2 (enExample) |
| WO (1) | WO2009127809A1 (enExample) |
| ZA (1) | ZA201006326B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110112101A1 (en) * | 2009-03-05 | 2011-05-12 | Sanofi-Aventis | Treatment for ocular-related disorders |
| JP5867926B2 (ja) * | 2010-05-10 | 2016-02-24 | 公立大学法人名古屋市立大学 | 細胞シート作製方法 |
| EP4245370A3 (en) | 2010-07-12 | 2023-11-29 | University of Southern California | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same |
| CN103459593A (zh) * | 2011-02-25 | 2013-12-18 | 独立行政法人理化学研究所 | 视网膜色素上皮细胞片层的生产方法 |
| US8877489B2 (en) | 2011-12-05 | 2014-11-04 | California Institute Of Technology | Ultrathin parylene-C semipermeable membranes for biomedical applications |
| US10478206B2 (en) | 2011-04-29 | 2019-11-19 | University Of Southern California | Instruments and methods for the implantation of cell-seeded substrates |
| WO2012177968A1 (en) * | 2011-06-22 | 2012-12-27 | The Schepens Eye Research Institute, Inc. | A scaffold for subretinal cell transplantation and drug delivery |
| US9763777B2 (en) | 2011-07-11 | 2017-09-19 | Ear Science Institute Australia | Device for ear drum repair |
| CN103007355B (zh) * | 2011-09-20 | 2014-08-13 | 同济大学 | 一种水凝胶-纳米纤维膜及其制备方法和用途 |
| CA2792081C (en) * | 2011-10-11 | 2020-10-27 | Bond University Ltd | Layered compositions comprising 3d nanofibre webbing for tissue repair |
| CA2855941A1 (en) | 2011-11-14 | 2013-05-23 | Advanced Cell Technology, Inc. | Pharmaceutical preparations of human rpe cells and uses thereof |
| US9248013B2 (en) | 2011-12-05 | 2016-02-02 | California Institute Of Technology | 3-Dimensional parylene scaffold cage |
| US20130330825A1 (en) * | 2012-06-07 | 2013-12-12 | City Of Hope | Attachment substrates for directed differentiation of human embryonic stem cells in culture |
| US11033586B2 (en) | 2012-08-24 | 2021-06-15 | Riken | Method for producing retinal pigment epithelial cell sheet |
| RU2518972C1 (ru) * | 2012-12-24 | 2014-06-10 | Общество с ограниченной ответственностью "НАНО КАСКАД" | Трековая мембрана для фильтрации крови |
| EP3080248A1 (en) | 2013-12-11 | 2016-10-19 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| CN105013010B (zh) * | 2015-07-07 | 2018-01-12 | 中山大学中山眼科中心 | 一种辅助iPS‑RPE移植的层粘连蛋白膜 |
| CN105597145A (zh) * | 2016-02-22 | 2016-05-25 | 中山大学中山眼科中心 | 一种视网膜细胞支架生物手术粘合剂及其制备方法 |
| CN109790508A (zh) * | 2016-06-28 | 2019-05-21 | 国立研究开发法人农业·食品产业技术综合研究机构 | 细胞封入用设备及其用途 |
| WO2020047380A1 (en) | 2018-08-31 | 2020-03-05 | Wisconsin Alumni Research Foundation | Generating arterial endothelial cell-seeded vascular grafts |
| TWI820330B (zh) * | 2019-04-26 | 2023-11-01 | 國立研究開發法人理化學研究所 | 包含神經視網膜與視網膜色素上皮細胞與水凝膠之複合體及其製造方法 |
| RU2704094C1 (ru) * | 2019-05-16 | 2019-10-23 | федеральное государственное автономное учреждение "Национальный медицинский исследовательский центр "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации | Способ трансплантации ретинального пигментного эпителия в форме многоклеточных 3D сфероидов в эксперименте |
| JP2021141877A (ja) * | 2020-03-13 | 2021-09-24 | 大日本印刷株式会社 | 細胞培養基材、細胞付細胞培養基材、細胞培養容器、細胞付細胞培養容器、上皮細胞シート及びその製造方法、被験物質の評価方法並びに評価キット |
| JP7676135B2 (ja) * | 2020-12-14 | 2025-05-14 | 日本バイリーン株式会社 | 細胞培養担体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0118984D0 (en) * | 2001-08-03 | 2001-09-26 | Intercytex Ltd | Fusion of cells |
| CN1739813A (zh) * | 2005-09-15 | 2006-03-01 | 上海赐人合元企业发展有限公司 | 组织工程表皮替代物及其制备方法 |
| KR100901343B1 (ko) | 2007-07-23 | 2009-06-05 | (주)실리콘화일 | 결정질 반도체 박막 제조 방법 |
| RU2368359C1 (ru) * | 2008-07-22 | 2009-09-27 | Государственное учреждение "УФИМСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ" Академии наук Республики Башкортостан (УфНИИ ГБ АН РБ) | Способ лечения возрастной макулярной дегенерации |
-
2008
- 2008-04-14 GB GBGB0806746.4A patent/GB0806746D0/en not_active Ceased
-
2009
- 2009-04-08 KR KR1020107022953A patent/KR101317094B1/ko not_active Expired - Fee Related
- 2009-04-08 CN CN200980113395.3A patent/CN102016009B/zh active Active
- 2009-04-08 DK DK09732279.6T patent/DK2265711T3/en active
- 2009-04-08 MX MX2010011232A patent/MX2010011232A/es active IP Right Grant
- 2009-04-08 US US12/933,694 patent/US8642072B2/en active Active
- 2009-04-08 KR KR1020137014211A patent/KR20130065737A/ko not_active Ceased
- 2009-04-08 RU RU2010144399/10A patent/RU2530169C2/ru not_active IP Right Cessation
- 2009-04-08 BR BRPI0910936A patent/BRPI0910936A2/pt not_active Application Discontinuation
- 2009-04-08 CA CA2720264A patent/CA2720264C/en active Active
- 2009-04-08 EP EP09732279.6A patent/EP2265711B1/en active Active
- 2009-04-08 NZ NZ587753A patent/NZ587753A/en unknown
- 2009-04-08 JP JP2011504521A patent/JP5552478B2/ja active Active
- 2009-04-08 AU AU2009237462A patent/AU2009237462B2/en active Active
- 2009-04-08 ES ES09732279.6T patent/ES2665284T3/es active Active
- 2009-04-08 WO PCT/GB2009/000917 patent/WO2009127809A1/en not_active Ceased
- 2009-04-08 MY MYPI2010004529A patent/MY159049A/en unknown
-
2010
- 2010-09-03 ZA ZA2010/06326A patent/ZA201006326B/en unknown
- 2010-10-14 IL IL208745A patent/IL208745A/en not_active IP Right Cessation
- 2010-11-12 CO CO10142317A patent/CO6311115A2/es active IP Right Grant
-
2014
- 2014-01-03 US US14/146,744 patent/US8889179B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| GB0806746D0 (en) | 2008-05-14 |
| EP2265711A1 (en) | 2010-12-29 |
| IL208745A0 (en) | 2010-12-30 |
| DK2265711T3 (en) | 2018-04-30 |
| WO2009127809A1 (en) | 2009-10-22 |
| MX2010011232A (es) | 2011-02-23 |
| KR101317094B1 (ko) | 2013-10-16 |
| KR20100128329A (ko) | 2010-12-07 |
| ZA201006326B (en) | 2011-09-28 |
| BRPI0910936A2 (pt) | 2015-10-06 |
| US8889179B2 (en) | 2014-11-18 |
| CN102016009A (zh) | 2011-04-13 |
| ES2665284T3 (es) | 2018-04-25 |
| IL208745A (en) | 2015-04-30 |
| MY159049A (en) | 2016-12-15 |
| CN102016009B (zh) | 2015-05-20 |
| JP5552478B2 (ja) | 2014-07-16 |
| CO6311115A2 (es) | 2011-08-22 |
| US8642072B2 (en) | 2014-02-04 |
| JP2011517696A (ja) | 2011-06-16 |
| US20140127282A1 (en) | 2014-05-08 |
| RU2010144399A (ru) | 2012-05-20 |
| EP2265711B1 (en) | 2018-03-07 |
| AU2009237462A1 (en) | 2009-10-22 |
| KR20130065737A (ko) | 2013-06-19 |
| RU2530169C2 (ru) | 2014-10-10 |
| CA2720264A1 (en) | 2009-10-22 |
| AU2009237462B2 (en) | 2012-12-20 |
| NZ587753A (en) | 2012-07-27 |
| US20110236464A1 (en) | 2011-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2720264C (en) | A membrane for supporting the growth of retinal pigmented epithelial cells | |
| Madden et al. | Human corneal endothelial cell growth on a silk fibroin membrane | |
| Kennedy et al. | Poly-ε-lysine based hydrogels as synthetic substrates for the expansion of corneal endothelial cells for transplantation | |
| Lu et al. | Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells | |
| Koo et al. | Micro-and nanotopography with extracellular matrix coating modulate human corneal endothelial cell behavior | |
| AU2016204936B2 (en) | Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same | |
| Shadforth et al. | The cultivation of human retinal pigment epithelial cells on Bombyx mori silk fibroin | |
| US5713957A (en) | Corneal onlays | |
| Subrizi et al. | Generation of hESC-derived retinal pigment epithelium on biopolymer coated polyimide membranes | |
| JP5946046B2 (ja) | ヒト角膜内皮細胞シート | |
| CN110225763A (zh) | 使用纤维蛋白支持物进行视网膜色素上皮移植的方法和材料 | |
| de la Mata et al. | Poly-l/dl-lactic acid films functionalized with collagen IV as carrier substrata for corneal epithelial stem cells | |
| JP2020006207A (ja) | 組織再生培養細胞シート、製造方法及びその利用方法 | |
| Lachaud et al. | Mesothelial cells: a cellular surrogate for tissue engineering of corneal endothelium | |
| WO2007043255A1 (ja) | 培養角膜内皮シート及びその作製方法 | |
| Daniele et al. | Denuded Descemet’s membrane supports human embryonic stem cell-derived retinal pigment epithelial cell culture | |
| HK1146092B (en) | Membrane | |
| HK1146092A (en) | Membrane | |
| Mishan et al. | Comparative culture of human corneal endothelial cells following treatment with human platelet lysate/fibrin hydrogel versus Y-27632 ROCK inhibitor: in vitro and ex vivo study | |
| Ramesh et al. | A bioengineered sequentially layered in vitro corneal construct | |
| Daniele | Age-Related Macular Degeneration: a new prospect in cell therapy | |
| WO2024185751A1 (ja) | 神経網膜前駆細胞を含む組織とその製造方法、該組織を含む網膜疾患治療用組成物 | |
| WO2024143436A1 (ja) | 網膜シートの製造方法 | |
| JP2011250804A (ja) | 上皮系細胞の重層化培養方法、それから得られる重層化上皮系細胞シート及びその利用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |